Primary CTS 2.0 Patent Is Granted by USPTO

Rhea-AI Summary

Alliance BioEnergy Plus, operating as Blue Biofuels, successfully secured its primary patent for the Cellulose-to-Sugar (CTS) technology. This milestone strengthens its ownership of core technology and aims to enhance competitive positioning. The company plans to file additional patents and is progressing towards manufacturing the 5th generation CTS system within 4 to 6 months. Promising developments in bioplastic production are underway, alongside expectations for cellulosic Renewable Fuel Credits (RINs) from the government, potentially increasing revenue streams.

Positive

• Secured primary patent for Cellulose-to-Sugar technology.
• Plans to file additional patents to strengthen IP portfolio.
• Progressing towards manufacturing 5th generation CTS system within 4 to 6 months.
• Developing bioplastic production process shows promising initial results.
• Potential eligibility for D3 Renewable Fuel Credits could increase revenue.

Negative

• None.

PALM BEACH GARDENS, FL, April 15, 2021 (GLOBE NEWSWIRE) -- Alliance BioEnergy Plus, Inc., DBA Blue Biofuels (PINK: ALLM).

Alliance BioEnergy Plus Inc., DBA Blue Biofuels, (the “Company”) is pleased to announce that the United States Patent and Trademark Office has granted the Company its primary patent on its Cellulose-to-Sugar technology system.

The Company has filed for an additional patent based on further development of the CTS system and is in the process of filing more additional patents.

CEO Ben Slager expressed that “Obtaining the key patent is a major technological achievement and ensures that the company is in full ownership of its core technology. The additional patents will further broaden our intellectual property landscape against potential competitors.”

The Company also reports that while testing will continue on its 4^th generation prototype, it has generated enough data to start the design and manufacture of the 5^th generation system which will be larger, more advanced, and more automated. The Company plans to have the 5^th generation in operation 4 to 6 months from today.

In parallel, the Company continues to develop the bioplastic production process related to the CTS process. First promising samples of bioplastics have been made. The Company has decided to put more effort and resources towards this part of the Company’s technological roadmap.

ABOUT OUR CLEAN TECHNOLOGY

CTS technology can convert virtually any plant material – grasses, wood, paper, farm waste, yard waste, forestry products, fruit casings, nut shells, and the cellulosic portion of municipal solid waste -- into sugars and subsequently into biofuels, and bioplastics, without the use of enzymes or liquid acids. CTS stands for Cellulose to Sugar. The cellulose is converted into sugar and lignin. The sugar is further converted into bio-ethanol and other biofuels. The lignin may be further converted into bioplastics. CTS has a near zero carbon footprint. The CTS process is an independently-developed patented and proprietary technology that is fully owned by the Company.

Management believes that bio-fuel originating from the Company’s CTS process will be eligible to receive generous D3 cellulosic Renewable Fuel Credits (“RINs”) from the US Government. The D3 RIN is currently $2.87/gallon of ethanol, which is in addition to the market price of ethanol. This incentive is offered to all domestic cellulosic fuel producers whose fuel is used in the transportation industry. This mandate was 590 million gallons for 2020. The mandate for 2021 has not yet been determined by the US Environmental Protection Agency.

Information in this document may constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The risks, uncertainties and other factors are more fully discussed in the Company's filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Alliance BioEnergy Plus, Inc. herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Alliance BioEnergy Plus, Inc. disclaims any obligation to update forward looking statements contained in this estimate, except as may be required by law. 

Contact:

Ben Slager, CEO
Ben@Bluebiofuels.com

Anthony Santelli, CFO
Anthony@Bluebiofuels.com

SOURCE: Alliance Bioenergy Plus, Inc. DBA Blue Biofuels www.Bluebiofuels.com

FAQ

What recent patent was granted to Alliance BioEnergy Plus (ALLM)?

Alliance BioEnergy Plus was granted its primary patent for its Cellulose-to-Sugar technology.

What are the future plans for Blue Biofuels' technology after securing its patent?

The company plans to file additional patents and manufacture the 5th generation CTS system within 4 to 6 months.

How does the Cellulose-to-Sugar technology benefit Alliance BioEnergy Plus financially?

The technology could make the company eligible for D3 Renewable Fuel Credits, which can boost revenue by $2.87 per gallon of ethanol produced.

What progress has been made on bioplastics at Alliance BioEnergy Plus (ALLM)?

The company has produced promising initial samples of bioplastics related to its CTS technology.

When was the patent for the Cellulose-to-Sugar technology announced by Alliance BioEnergy Plus?

The patent announcement was made on April 15, 2021.